Sumatriptan and Naproxen Sodium

Innovida Phamaceutique Corporation🇺🇸 United States

FDA Page

Effective Date: Dec 10, 2020
Approval ID: 6c0c9268-315d-4c0a-943f-58b21b738d11
Products: 1 registered
Version: 1

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use SUMATRIPTAN AND NAPROXEN SODIUM TABLETS safely and effectively. See full prescribing information for SUMATRIPTAN AND NAPROXEN SODIUM TABLETS. SUMATRIPTAN and NAPROXEN SODIUM tablets, for oral use Initial U.S. Approval: 2008

Quick Stats

Total Products1

Labelers2

Label Sections18

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.